Patheon acquires Bend’s Agere Pharmaceuticals
Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, said Monday it has reached a definitive agreement to acquire Agere Pharmaceuticals, a privately held CDMO, headquartered in Bend, Ore., that specializes in improving the absorption rate of medications (bioavailability). Agere is a contract development marketing organization
Continue Reading